22 December 2025
22 December 2025
GLP-1 drugs and “multi-sensory indulgence” are among the forces set to influence what consumers buy next year, according to new research.
The transaction values Twizza at an enterprise value of R2.09bn ($125.4m), to be settled in cash.
James B. Beam Distilling Company said it would "take the opportunity to invest in site enhancements".
The German brewer has agreed with trade union NGG to increase wages by 3.8% from next year.
Michael Söhlke joined the business as CFO in 2020.
The Polish president Karol Nawrocki has argued that increasing the price of sugar-sweetened drinks would "trigger short-term consumer reactions".
The deal, which sees Asahi take over Diageo's Kenyan assets, including its stake in East African Breweries, has surprised several industry analysts.
The US president wants medical marijuana adopted as a Schedule III drug along the same lines as painkillers.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
